EWZ vs IBB

iShares MSCI Brazil ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.59% for EWZ.
  • EWZ pays a higher dividend yield (4.16%).

Side-by-side metrics

MetricEWZIBB
Expense ratio
Annual fee. Lower is better.
0.59%0.44%
Dividend yield
Trailing 12-month yield.
4.16%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$11.57B$7.95B
YTD return
25.59%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.020.74
P/E ratio
12.4723.72
Last price
$38.80$170.10
Inception
Issuer
iSharesiShares

EWZ top holdings

Top holdings · EWZ
VALE3.SAVale SA10.39%
NUNu Holdings Ltd Ordinary Shares Class A8.74%
ITUB4Itau Unibanco Holding SA Participating Preferred8.43%
PETR4Petroleo Brasileiro SA Petrobras Participating Preferred7.84%
PETR3.SAPetroleo Brasileiro SA Petrobras7.23%
B3SA3.SAB3 SA - Brasil Bolsa Balcao3.60%
BBDC4Bank Bradesco SA Participating Preferred3.35%
SBSP3.SACompanhia De Saneamento Basico Do Estado De Sao Paulo3.12%
AXIA3.SAAxia Energia2.87%
WEGE3.SAWeg SA2.85%
Sector breakdown · EWZ
Consumer Cyclical1.5%
Basic Materials13.7%
Consumer Defensive4.2%
Technology0.9%
Communication Services2.2%
Financial Services32.7%
Utilities12.9%
Industrials10.9%
Energy18.5%
Healthcare2.4%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About EWZ

EWZ (iShares MSCI Brazil ETF) is Brazilian large- and mid-cap equities. Managed by iShares, the fund carries $11.6B in assets under management, an expense ratio of 0.59%, a dividend yield of 4.16%. Its largest holding is Vale SA (VALE3.SA), which represents 10.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.5%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.